The scientific term for T-lymphoblastic leukemia is T-lymphoblastic lymphoma, which can be treated with bone marrow transplantation, but not all patients need to be treated with bone marrow transplantation. 1. T-lymphoblastic lymphoma is a malignant hematologic disease with high malignancy and poor prognosis, which can be treated by combination chemotherapy, targeted therapy or bone marrow transplantation. For patients older than 65 years old, combination chemotherapy plus targeted drug therapy may be preferred. However, combination chemotherapy and targeted drug therapy are difficult to completely cure the disease, and the disease may relapse again after achieving remission. Specific drugs include cyclophosphamide, vincristine, dexamethasone, cedarbenazine and so on. 2. Hematopoietic stem cell transplantation is the fundamental cure for malignant blood diseases. For young patients, bone marrow transplantation is preferred. Bone marrow transplantation includes autologous HSCT and allogeneic HSCT, which should be recommended by hematologists according to the patient’s specific condition and economic conditions and other factors, and the treatment plan should be determined after communicating with the patient and his/her family.